Monica Martinez-Fernandez
@monikmarfer.bsky.social
📤 78
📥 171
📝 9
Mum & Leader of Traslational Molecular Oncology at @iisgaliciasur
pinned post!
So honored to have been selected for the
#CaixaImpulse
stage two. Thank you so much
@caixaresearch.bsky.social
for this challenging opportunity!!
4 months ago
1
3
2
reposted by
Monica Martinez-Fernandez
4 months ago
Congratulations, Mónica! We are looking forward to seeing your project evolve and make an impact! 👏
add a skeleton here at some point
0
1
1
So honored to have been selected for the
#CaixaImpulse
stage two. Thank you so much
@caixaresearch.bsky.social
for this challenging opportunity!!
4 months ago
1
3
2
reposted by
Monica Martinez-Fernandez
4 months ago
🫁 El cáncer de pulmón avanzado es un gran reto y su evaluación es costosa y dolorosa. Con el apoyo de #CaixaImpulse Innovación,
@monikmarfer.bsky.social
#CaixaImpulse
(IISGS) desarrolla un test de sangre para conocer la probabilidad del paciente de beneficiarse de los tratamientos.
https://tinyurl.com/wekntpbm
1
2
1
Proud PI
7 months ago
0
2
0
Our RetroTest is finally out! An easy and accesible way to measure retrotransposon LINE-1 activation in clinical samples. We found that this activity kicks in very early in HNSCC tumors. Take a look 🤓👇
febs.onlinelibrary.wiley.com/doi/10.1002/...
loading . . .
FEBS Press
The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied Retro...
https://febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.70063
8 months ago
0
3
0
Happy to share our freshly baked work on how genomics can predict the response to first line icis in advanced lung and bladder cancer patients
link.springer.com/article/10.1...
loading . . .
Genomics guiding personalized first-line immunotherapy response in lung and bladder tumors - Journal of Translational Medicine
Background Immune checkpoint inhibitors (ICI) have revolutionized cancer treatment, particularly in advanced non-small cell lung cancer (NSCLC) and muscle-invasive bladder cancer (MIBC). However, iden...
https://link.springer.com/article/10.1186/s12967-025-06323-7?utm_source=rct_congratemailt&utm_medium=email&utm_campaign=oa_20250405&utm_content=10.1186%2Fs12967-025-06323-7
10 months ago
0
6
1
Este miércoles, tenemos la suerte de contar con Toni Celià
@tceliaterrassa.bsky.social
en el
#IISGalicia_Sur
para hablarnos de su investigación más reciente, no os lo perdáis!!
10 months ago
0
4
2
Hoy el alumnado de primero de bach del IES Alexandre Boveda de Vigo ha hecho mi mañana un poquito mejor, muchas gracias!
#SinCienciaNoHayFuturo
#iisgaliciasur
11 months ago
0
2
0
Un
#11F
más, acercando
#CONÓCELAS
a l@s alumn@s, este año del
#IESStoTomé
de Vigo, de la mano de
@aseica.bsky.social
y el
#iisgaliciasur
12 months ago
0
3
2
reposted by
Monica Martinez-Fernandez
Ana Blasco
12 months ago
Porque tres meses para probar un tratamiento es mucho tiempo para un paciente con cáncer de pulmón
add a skeleton here at some point
0
1
1
Gracias al
@farodevigo.es
@anablasco.bsky.social
por hacerse eco del trabajo de Oncología Traslacional del @IISGaliciaSur
www.farodevigo.es/gran-vigo/20...
loading . . .
Predecir el éxito de la inmunoterapia en cáncer pulmón con un análisis de sangre
Oncología Traslacional del Galicia Sur patenta la primera firma de biomarcadores para saber si un paciente responderá
https://www.farodevigo.es/gran-vigo/2025/02/04/predecir-exito-inmunoterapia-cancer-pulmon-113972117.html
12 months ago
1
3
1
Manu has the opportunity of presenting today our latest results in NSCLC patients using
#biopsia_liquida
. Congrats to
@oncomet.bsky.social
for this inspiring X symposium
12 months ago
1
4
1
you reached the end!!
feeds!
log in
